Arbutus to Participate in H.C Wainwright @ Home Virtual Fireside Chat
26 nov. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...